StocksA › AMSC

American Superconductor Corporation (AMSC) — Earnings Call X-Ray

Our AI read all 39 of AMSC's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q4 2024 · sign up to see
Previous Call Grade
A
Q3 2024
Expected Move
🔒
next 45 days · members
Calls Analyzed
39
2016–2025
Avg Candor
6.5/9
evasion 3.3/9
Guidance RaisedHigh CandorPromotional ToneSkeptic ReassuredClean CallVolume Step-UpUnderused Fixed CostsMargins Expanding

Call-by-call analysis

🔒 Q4 2024 earnings call 2025-05-22 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q4 2024 call grade is ready
The full 37-point AI read of AMSC's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

A Q3 2024 earnings call 2025-02-06 move ±20.9%

Management raised guidance against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.

Guidance: raisedDemand: acceleratingMargins: expandingBacklog: growingCapex: flat 3 analysts · 8 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead
Candor 7/9
Specificity 7/9
Evasion 2/9
Confidence 9/9
Uncertainty 3/9
Promotion 7/9
Stress 1/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
From the research question bank
1 more research questions answered NO

C+ Q2 2025 earnings call 2024-10-31 move ±27.3%

Management held guidance steady against accelerating demand and expanding margins. The delivery was rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: expandingBacklog: growingPricing: raisingCapex: flat 3 analysts · 7 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Volume step-up ahead
Candor 6/9
Specificity 8/9
Evasion 4/9
Confidence 8/9
Uncertainty 3/9
Promotion 6/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q1 2024 earnings call 2024-08-09 move ±14.6%

Management held guidance steady against accelerating demand and expanding margins. The delivery was rich in specifics, relaxed under questioning, promotional in tone.

Guidance: maintainedDemand: acceleratingMargins: expandingBacklog: growingPricing: raising 3 analysts · 7 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Resolves doubts✓ Volume step-up ahead✓ Early product, fast growth
Candor 6/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 4/9
Promotion 8/9
Stress 1/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q4 2023 earnings call 2024-05-31 move ±17.7%

Management held guidance steady against accelerating demand and expanding margins. The delivery was rich in specifics, relaxed under questioning, promotional in tone.

Guidance: maintainedDemand: acceleratingMargins: expandingBacklog: growingPricing: stableCapex: flat 3 analysts · 8 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 8/9
Uncertainty 3/9
Promotion 7/9
Stress 1/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q3 2023 earnings call 2024-01-25 move ±21.1%

Management held guidance steady against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.

Guidance: maintainedDemand: acceleratingMargins: expandingBacklog: growingPricing: raising 3 analysts · 8 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead✓ Early product, fast growth
Candor 7/9
Specificity 7/9
Evasion 3/9
Confidence 9/9
Uncertainty 3/9
Promotion 7/9
Stress 1/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
YES Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B+ Q2 2023 earnings call 2023-11-02 move ±17.1%

Management held guidance steady against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.

Guidance: maintainedDemand: acceleratingMargins: expandingBacklog: growingPricing: raising 3 analysts · 6 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 3/9
Promotion 6/9
Stress 1/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q1 2023 earnings call 2023-08-10 move ±38.9%

Management held guidance steady against accelerating demand and expanding margins. The delivery was rich in specifics, promotional in tone.

Guidance: maintainedDemand: acceleratingMargins: expandingBacklog: growingPricing: raising 3 analysts · 7 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 8/9
Uncertainty 4/9
Promotion 7/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q4 2022 2023-06-01 C+ maintainedacceleratingexpanding 7/9 2/9
Q3 2022 2023-02-02 C+ maintainedacceleratingcontracting 7/9 2/9
Q2 2022 2022-11-02 C maintainedacceleratingcontracting 7/9 3/9
Q1 2022 2022-08-07 C maintainedacceleratingcontracting 6/9 3/9
Q4 2021 2022-06-02 D loweredacceleratingcontracting 7/9 3/9
Q3 2021 2022-02-03 C+ maintainedacceleratingcontracting 7/9 2/9
Q2 2021 2021-11-09 C+ maintainedacceleratingcontracting 7/9 3/9
Q1 2021 2021-08-07 C+ maintainedacceleratingcontracting 7/9 3/9
Q4 2020 2021-06-03 C+ noneacceleratingexpanding 6/9 2/9
Q3 2020 2021-02-04 F loweredmixedexpanding 6/9 4/9
Q2 2020 2020-11-08 B+ maintainedacceleratingstable 6/9 2/9
Q2 2020 2020-11-05 C+ maintainedacceleratingstable 6/9 3/9
Q1 2020 2020-08-09 C maintainedacceleratingexpanding 6/9 4/9
Q4 2020 2020-06-03 C maintainedmixedcontracting 6/9 4/9
Q3 2019 2020-02-06 C maintainedacceleratingcontracting 6/9 4/9
Q2 2019 2019-11-10 D maintainedmixedexpanding 7/9 3/9
Q1 2019 2019-08-10 D maintainedacceleratingcontracting 7/9 4/9
Q4 2018 2019-06-06 D loweredmixedexpanding 6/9 4/9
Q3 2018 2019-02-06 D maintainedmixedcontracting 6/9 4/9
Q2 2018 2018-11-08 D maintainedstableexpanding 6/9 6/9
Q1 2018 2018-08-01 C+ maintainedacceleratingexpanding 6/9 4/9
Q4 2017 2018-06-07 F maintainedmixedexpanding 6/9 4/9
Q3 2017 2018-02-06 C maintainedmixedexpanding 7/9 3/9
Q3 2017 2017-11-11 D maintainedmixedcontracting 6/9 4/9
Q1 2017 2017-08-10 D maintainedmixedcontracting 6/9 4/9
Q4 2016 2017-05-25 F loweredmixedcontracting 7/9 4/9
Q3 2016 2017-02-06 D maintainedacceleratingcontracting 6/9 5/9
Q2 2016 2016-11-03 D maintainedmixedunclear 7/9 5/9
Q1 2016 2016-08-09 D loweredmixedcontracting 8/9 4/9
Q4 2015 2016-05-31 D loweredmixedexpanding 7/9 2/9
Q3 2015 2016-02-09 C loweredmixedexpanding 6/9 2/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of AMSC's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

C Q3 2017 earnings call 2018-02-06

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAXN · Axon Enterprise'sACIC · American Coastal InsuranACSAF · ACS, Actividades de ConsACU · Acme United CorporationADC · Agree Realty CorporationADPT · Adaptive Biotechnologies

AMS   All “A” companies    AMSF

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.